ArticleSaudi journal of biological sciences2020
Biogenic synthesis of silver nanoparticles: Antibacterial and cytotoxic potential.
Article in Saudi journal of biological sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 65 citations in OpenAlex.
- Fungal-Based Biogenic Silver Nanoparticles: Synthesis, Mathematical Modeling and Application.Molecules (Basel, Switzerland) · 2026Article
- Novel biogenic silver nanoparticles produced byNanoscale advances · 2026Article
- A Novel Integrated Approach: Plant-Mediated Synthesis, in vitro and in silico Evaluation of Silver Nanoparticles for Breast Cancer and Bacterial Therapies.International journal of nanomedicine · 2025Article
- Article
- Phytosynthesis of Silver Nanoparticles UsingPharmaceutics · 2024Article
- Plackett-Burman screening of physico-chemical variables affecting Citrus peel-mediated synthesis of silver nanoparticles and their antimicrobial activity.Scientific reports · 2024Article
- Silver Nanoparticles Phytofabricated throughAntibiotics (Basel, Switzerland) · 2023Article
- Plant-mediated synthesis of silver nanoparticles: unlocking their pharmacological potential-a comprehensive review.Frontiers in bioengineering and biotechnology · 2023Review
- Use of biogenic silver nanoparticles on the cathode to improve bioelectricity production in microbial fuel cells.Frontiers in chemistry · 2023Article
- Article
- Recent advances of metal-based nanoparticles in nucleic acid delivery for therapeutic applications.Journal of nanobiotechnology · 2022Review
- Synthesis of Green Engineered Silver Nanoparticles throughAntibiotics (Basel, Switzerland) · 2022Article
- Sustainable phyto-fabrication of silver nanoparticles using Gmelina arborea exhibit antimicrobial and biofilm inhibition activity.Scientific reports · 2022Article
- Biosynthesis of silver nanoparticles using extract ofFrontiers in molecular biosciences · 2022Article
- The Antimicrobial Potential of the Neem TreeFrontiers in pharmacology · 2022Review
- Synergistic antibacterial activity of compact silver/magnetite core-shell nanoparticles core shell against Gram-negative foodborne pathogens.Frontiers in microbiology · 2022Article
- One-pot fabrication of Ag @AgScientific reports · 2021Article
- Phytoproduct, Arabic Gum andNanomaterials (Basel, Switzerland) · 2021Article
- Biological Potential of Silver Nanoparticles Mediated byNanomaterials (Basel, Switzerland) · 2021Article
- Green Synthesis of Silver Nanoparticles Using Natural Extracts with Proven Antioxidant Activity.Molecules (Basel, Switzerland) · 2021Article
Corrections and comments
- Erratum issued
Authors and funding
4 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In green chemistry, the application of a biogenic material as a mediator in nanoparticles formation is an innovative nanotechnology. Our current investigation aimed at testing the cytotoxic potential and antimicrobial ability of silver nanoparticles (AgNPs) that were prepared using
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.